Evolent Health has registered a secondary public offering of 7.5 million class A common shares.
UPMC, a number of TPG Global LLC affiliates, Ptolemy Capital LLC and Advisory Board Co. are the selling shareholders. The underwriters have a 30-day option to buy up to about 1.1 million additional class A common shares.
The company is not offering any shares and will not receive any proceeds.
J.P. Morgan Securities LLC and Goldman Sachs & Co. are the offering's joint book-running managers and underwriters.